Skip to main content
Toggle navigation
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Print
Debate: Should AML or MDS patients with TP53 Mutations Undergo Allogeneic Stem Cell Transplantation: Yes
Wednesday, October 19, 2022
3:15 PM – 3:30 PM